Editas Medicine (EDIT) Other Accumulated Expenses (2015 - 2023)

Editas Medicine (EDIT) has 9 years of Other Accumulated Expenses data on file, last reported at $78000.0 in Q2 2023.

• On a quarterly basis, Other Accumulated Expenses fell 97.18% year-over-year to $78000.0 in Q2 2023; TTM through Jun 2023 was $78000.0, a 97.18% decrease from a year earlier, with the FY2022 full-year figure at $1.6 million, up 16.12% from the prior year.
• Other Accumulated Expenses for Q2 2023 stood at $78000.0, down from $109000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for EDIT reached as high as $4.0 million in Q2 2020 and fell as low as $78000.0 in Q2 2023.
• Historically, Other Accumulated Expenses has averaged $1.2 million across 5 years, with a median of $862000.0 in 2021.
• Across the five-year window, Other Accumulated Expenses jumped 1044.03% in 2020 and tumbled 97.18% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $2.7 million in 2019, then slumped by 57.87% to $1.1 million in 2020, then gained by 24.6% to $1.4 million in 2021, then grew by 16.12% to $1.6 million in 2022, then plunged by 95.23% to $78000.0 in 2023.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $78000.0 in Q2 2023, $109000.0 in Q1 2023, and $1.6 million in Q4 2022.